Association between CYP2D6 genotype and tardive dyskinesia in Korean schizophrenics

D. Nikoloff, J. C. Shim, M. Fairchild, N. Patten, B. A. Fijal, W. H. Koch, A. MacPherson, D. Flockhart, Y. R. Yoon, J. S. Yoon, Y. H. Kim, J. G. Shin

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The CYP2D6 gene codes for human cytochrome P450 2D6 enzyme, which is responsible for the metabolism of many psychiatric drugs. In schizophrenic patients treated with neuroleptics, decreased or loss of function CYP2D6 alleles may contribute to the development of tardive dyskinesia (TD), a movement disorder that frequently occurs with chronic neuroleptic treatment. The goal of this study was to determine whether the occurrence of TD is associated with CYP2D6 genotype in a cohort of Korean schizophrenics by employing a CYP450 GeneChip® oligonucleotide microarray and PCR assays to screen for 19 CYP2D6 alleles. Our results revealed that males with at least one decreased or loss of function allele have a moderately greater chance of developing TD than males with only wild-type alleles. Female schizophrenics did not have a significantly greater chance of developing TD. Our results demonstrate the utility of CYP2D6 microarrays to assess genotype status in this Korean cohort.

Original languageEnglish
Pages (from-to)400-407
Number of pages8
JournalPharmacogenomics Journal
Volume2
Issue number6
DOIs
StatePublished - 2002

Fingerprint

Cytochrome P-450 CYP2D6
Genotype
Alleles
Antipsychotic Agents
Movement Disorders
Oligonucleotide Array Sequence Analysis
Cytochrome P-450 Enzyme System
Psychiatry
Tardive Dyskinesia
Polymerase Chain Reaction
Pharmaceutical Preparations
Genes

Keywords

  • CYP2D6
  • Genotyping
  • Tardive dyskinesia

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine
  • Genetics

Cite this

Nikoloff, D., Shim, J. C., Fairchild, M., Patten, N., Fijal, B. A., Koch, W. H., ... Shin, J. G. (2002). Association between CYP2D6 genotype and tardive dyskinesia in Korean schizophrenics. Pharmacogenomics Journal, 2(6), 400-407. https://doi.org/10.1038/sj.tpj.6500138

Association between CYP2D6 genotype and tardive dyskinesia in Korean schizophrenics. / Nikoloff, D.; Shim, J. C.; Fairchild, M.; Patten, N.; Fijal, B. A.; Koch, W. H.; MacPherson, A.; Flockhart, D.; Yoon, Y. R.; Yoon, J. S.; Kim, Y. H.; Shin, J. G.

In: Pharmacogenomics Journal, Vol. 2, No. 6, 2002, p. 400-407.

Research output: Contribution to journalArticle

Nikoloff, D, Shim, JC, Fairchild, M, Patten, N, Fijal, BA, Koch, WH, MacPherson, A, Flockhart, D, Yoon, YR, Yoon, JS, Kim, YH & Shin, JG 2002, 'Association between CYP2D6 genotype and tardive dyskinesia in Korean schizophrenics', Pharmacogenomics Journal, vol. 2, no. 6, pp. 400-407. https://doi.org/10.1038/sj.tpj.6500138
Nikoloff, D. ; Shim, J. C. ; Fairchild, M. ; Patten, N. ; Fijal, B. A. ; Koch, W. H. ; MacPherson, A. ; Flockhart, D. ; Yoon, Y. R. ; Yoon, J. S. ; Kim, Y. H. ; Shin, J. G. / Association between CYP2D6 genotype and tardive dyskinesia in Korean schizophrenics. In: Pharmacogenomics Journal. 2002 ; Vol. 2, No. 6. pp. 400-407.
@article{4070d190d02542d490456e3281e8f7c1,
title = "Association between CYP2D6 genotype and tardive dyskinesia in Korean schizophrenics",
abstract = "The CYP2D6 gene codes for human cytochrome P450 2D6 enzyme, which is responsible for the metabolism of many psychiatric drugs. In schizophrenic patients treated with neuroleptics, decreased or loss of function CYP2D6 alleles may contribute to the development of tardive dyskinesia (TD), a movement disorder that frequently occurs with chronic neuroleptic treatment. The goal of this study was to determine whether the occurrence of TD is associated with CYP2D6 genotype in a cohort of Korean schizophrenics by employing a CYP450 GeneChip{\circledR} oligonucleotide microarray and PCR assays to screen for 19 CYP2D6 alleles. Our results revealed that males with at least one decreased or loss of function allele have a moderately greater chance of developing TD than males with only wild-type alleles. Female schizophrenics did not have a significantly greater chance of developing TD. Our results demonstrate the utility of CYP2D6 microarrays to assess genotype status in this Korean cohort.",
keywords = "CYP2D6, Genotyping, Tardive dyskinesia",
author = "D. Nikoloff and Shim, {J. C.} and M. Fairchild and N. Patten and Fijal, {B. A.} and Koch, {W. H.} and A. MacPherson and D. Flockhart and Yoon, {Y. R.} and Yoon, {J. S.} and Kim, {Y. H.} and Shin, {J. G.}",
year = "2002",
doi = "10.1038/sj.tpj.6500138",
language = "English",
volume = "2",
pages = "400--407",
journal = "Pharmacogenomics Journal",
issn = "1470-269X",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Association between CYP2D6 genotype and tardive dyskinesia in Korean schizophrenics

AU - Nikoloff, D.

AU - Shim, J. C.

AU - Fairchild, M.

AU - Patten, N.

AU - Fijal, B. A.

AU - Koch, W. H.

AU - MacPherson, A.

AU - Flockhart, D.

AU - Yoon, Y. R.

AU - Yoon, J. S.

AU - Kim, Y. H.

AU - Shin, J. G.

PY - 2002

Y1 - 2002

N2 - The CYP2D6 gene codes for human cytochrome P450 2D6 enzyme, which is responsible for the metabolism of many psychiatric drugs. In schizophrenic patients treated with neuroleptics, decreased or loss of function CYP2D6 alleles may contribute to the development of tardive dyskinesia (TD), a movement disorder that frequently occurs with chronic neuroleptic treatment. The goal of this study was to determine whether the occurrence of TD is associated with CYP2D6 genotype in a cohort of Korean schizophrenics by employing a CYP450 GeneChip® oligonucleotide microarray and PCR assays to screen for 19 CYP2D6 alleles. Our results revealed that males with at least one decreased or loss of function allele have a moderately greater chance of developing TD than males with only wild-type alleles. Female schizophrenics did not have a significantly greater chance of developing TD. Our results demonstrate the utility of CYP2D6 microarrays to assess genotype status in this Korean cohort.

AB - The CYP2D6 gene codes for human cytochrome P450 2D6 enzyme, which is responsible for the metabolism of many psychiatric drugs. In schizophrenic patients treated with neuroleptics, decreased or loss of function CYP2D6 alleles may contribute to the development of tardive dyskinesia (TD), a movement disorder that frequently occurs with chronic neuroleptic treatment. The goal of this study was to determine whether the occurrence of TD is associated with CYP2D6 genotype in a cohort of Korean schizophrenics by employing a CYP450 GeneChip® oligonucleotide microarray and PCR assays to screen for 19 CYP2D6 alleles. Our results revealed that males with at least one decreased or loss of function allele have a moderately greater chance of developing TD than males with only wild-type alleles. Female schizophrenics did not have a significantly greater chance of developing TD. Our results demonstrate the utility of CYP2D6 microarrays to assess genotype status in this Korean cohort.

KW - CYP2D6

KW - Genotyping

KW - Tardive dyskinesia

UR - http://www.scopus.com/inward/record.url?scp=12244299890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12244299890&partnerID=8YFLogxK

U2 - 10.1038/sj.tpj.6500138

DO - 10.1038/sj.tpj.6500138

M3 - Article

C2 - 12629505

AN - SCOPUS:12244299890

VL - 2

SP - 400

EP - 407

JO - Pharmacogenomics Journal

JF - Pharmacogenomics Journal

SN - 1470-269X

IS - 6

ER -